Cytarabine Injection, Solution
Product Images NDC 71288-169

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 71288-169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Cyt03 0000 01)

Structure (Cyt03 0000 01)
FDA Label Image

Principal Display Panel – Cytarabine Injection 500 mg Per 25 mL Vial Label (Cyt03 0000 02)

Principal Display Panel – Cytarabine Injection 500 mg Per 25 mL Vial Label (Cyt03 0000 02)
FDA Label Image

Principal Display Panel – Cytarabine Injection 500 mg Per 25 mL Carton (Cyt03 0000 03)

Principal Display Panel – Cytarabine Injection 500 mg Per 25 mL Carton (Cyt03 0000 03)
This appears to be a label for a pharmaceutical product called Cytarabine that is in injection form. The label provides information on the contents of the product, storage instructions, usage instructions, and warnings. The product should not be used intrathecally or at high doses. The label also warns that the product is a cytotoxic agent. It is not clear what the text at the beginning of the label pertains to.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.